MGTCX
Price
$8.47
Change
-$0.04 (-0.47%)
Updated
Sep 20 closing price
RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

MGTCX vs RPTIX

Header iconMGTCX vs RPTIX Comparison
Open Charts MGTCX vs RPTIXBanner chart's image
Transamerica Mid Cap Growth C
Price$8.47
Change-$0.04 (-0.47%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
MGTCX vs RPTIX Comparison Chart
Loading...
VS
MGTCX vs. RPTIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGTCX is a StrongBuy and RPTIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. MGTCX (144M). RPTIX pays higher dividends than MGTCX: RPTIX (0.18) vs MGTCX (0.00). MGTCX was incepted earlier than RPTIX: MGTCX (11 years) vs RPTIX (9 years). MGTCX is a more actively managed with annual turnover of: 75.00 vs. RPTIX (21.70). MGTCX has a lower initial minimum investment than RPTIX: MGTCX (1000) vs RPTIX (500000). MGTCX annual gain was more profitable for investors over the last year : 19.12 vs. RPTIX (11.14). RPTIX return over 5 years is better than : 14.15 vs. MGTCX (-12.57).
MGTCXRPTIXMGTCX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years9 years-
Gain YTD9.0088.239109%
Front LoadN/AN/A-
Min. Initial Investment10005000000%
Min. Initial Investment IRAN/AN/A-
Net Assets144M31.4B0%
Annual Yield % from dividends0.000.18-
Returns for 1 year19.1211.14172%
Returns for 3 years-39.80-15.49257%
Returns for 5 years-12.5714.15-89%
Returns for 10 years-23.95N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XNET1.630.01
+0.62%
Xunlei Limited
OMI15.81-0.06
-0.38%
Owens & Minor
BWXT97.09-0.68
-0.70%
BWX Technologies
ZVSA2.43-0.04
-1.62%
ZyVersa Therapeutics
SNDL2.13-0.08
-3.62%
SNDL